Get the Stockscreener App
6.08
8.57%
-0.57
After Hours:
6.03
-0.05
-0.82%
Electrocore Inc stock is traded at $6.08, with a volume of 149.06K.
It is down -8.57% in the last 24 hours and down -6.46% over the past month.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
See More
Previous Close:
$6.65
Open:
$6.7
24h Volume:
149.06K
Relative Volume:
1.98
Market Cap:
$49.15M
Revenue:
$32.03M
Net Income/Loss:
$-13.97M
P/E Ratio:
-3.60
EPS:
-1.6889
Net Cash Flow:
$-8.25M
1W Performance:
-10.59%
1M Performance:
-6.46%
6M Performance:
+21.60%
1Y Performance:
+10.14%
1-Day Range:
$5.71
$7.12
1-Week Range:
$5.71
$7.45
52-Week Range:
$4.16
$8.64
Electrocore Inc Stock (ECOR) Company Profile
Name
Electrocore Inc
Sector
Industry
Phone
973-290-0097
Address
200 FORGE WAY, ROCKAWAY
Compare ECOR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ECOR
Electrocore Inc
|
6.08 | 49.15M | 32.03M | -13.97M | -8.25M | -1.6889 |
ABT
Abbott Laboratories
|
100.30 | 174.29B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
339.15 | 129.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.21 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.79 | 91.83B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
77.87 | 44.90B | 6.07B | 1.06B | 1.34B | 1.8063 |
Electrocore Inc Stock (ECOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-14-20 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-14-19 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Sep-26-19 | Resumed | Cantor Fitzgerald | Neutral |
| May-30-19 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| May-15-19 | Downgrade | BTIG Research | Buy → Neutral |
| May-09-19 | Initiated | Noble Capital Markets | Outperform |
| Sep-21-18 | Initiated | Cantor Fitzgerald | Overweight |
View All
Electrocore Inc Stock (ECOR) Latest News
Analyst Upgrade: Is electroCore Inc stock a value trapMarket Sentiment Summary & High Conviction Investment Ideas - baoquankhu1.vn
electroCore (ECOR) Rises 7.1%: Can This Momentum Continue? - Bitget
electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last? - Yahoo Finance
Shorts Report: Will electroCore Inc outperform during market rallies2026 Sector Moves & AI Driven Price Forecasts - baoquankhu1.vn
Bond Watch: Whats the outlook for electroCore Incs sector2026 Price Swings & Reliable Price Breakout Alerts - baoquankhu1.vn
electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference - Bitget
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD - Sahm
ElectroCore (ECOR) Advances PTSD Treatment Study - GuruFocus
ElectroCore Announces First Patient Enrollmen - Moomoo
PTSD treatment study begins with 8 patients using electroCore device - Stock Titan
electroCore Inc. R (43E0.F) Q2 FY2025 earnings call transcript - Yahoo Finance
electroCore, Inc. (ECOR) stock price, news, quote and history - Yahoo Finance UK
electroCore reports study on nerve stimulation for brain injury By Investing.com - Investing.com South Africa
electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD - Sahm
electroCore (ECOR) CFO Joshua Lev receives 45,000 RSU equity grant - Stock Titan
ECOR | electroCore, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
electroCore reports study on nerve stimulation for brain injury - Investing.com
ECOR PE Ratio & Valuation, Is ECOR Overvalued - Intellectia AI
Electrocore announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
ElectroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
electroCore receives two U.S. patents for nerve stimulation tech By Investing.com - Investing.com South Africa
electroCore adds a COO and sales VP, with 100,000 RSUs attached - Stock Titan
Momentum Shift: Can electroCore Inc deliver alphaQuarterly Trade Review & Reliable Breakout Stock Forecasts - baoquankhu1.vn
electroCore (ECOR) Secures Two New U.S. Patents for Vagus Nerve Modulation - GuruFocus
electroCore receives two U.S. patents for nerve stimulation tech - Investing.com
electroCore Expands Intellectual Property Portfolio - ChartMill
Published on: 2026-03-28 12:14:09 - baoquankhu1.vn
Growth Value: Whats the analyst consensus on electroCore IncEntry Point & Precise Entry and Exit Recommendations - baoquankhu1.vn
Retail Surge: Is electroCore Inc being accumulated by smart money2026 Chart Watch & AI Optimized Trade Strategies - baoquankhu1.vn
Earnings Beat: Is electroCore Inc stock overvalued or fairly priced2026 Short Interest & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Aug Update: Is electroCore Inc stock a value trap2026 WrapUp & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Aug Retail: Is electroCore Inc stock a value trap2026 Patterns & Reliable Price Action Trade Plans - baoquankhu1.vn
Market Review: Will electroCore Inc benefit from rate cuts2026 Trends & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances - MSN
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
Why Is electroCore, Inc. (ECOR) Stock Down Today? - meyka.com
electroCore Inc (ECOR) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Initiatives - GuruFocus
Hedge Fund Moves: Does electroCore Inc meet Warren Buffetts criteria2026 Catalysts & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Analysts Offer Predictions for electroCore FY2030 Earnings - MarketBeat
CEO Moves: Should value investors consider electroCore IncMarket Risk Analysis & Reliable Entry Point Alerts - baoquankhu1.vn
Electrocore’s gammaCore Pipeline Faces Material Trial Disruption Risks From Regulatory, Enrollment and Operational Challenges - theglobeandmail.com
Analysts Offer Insights on Healthcare Companies: Electrocore (ECOR) and Regeneron (REGN) - The Globe and Mail
ElectroCore FY earnings preview - MSN
Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX) and Electrocore (ECOR) - The Globe and Mail
ElectroCore Earnings Call: Growth Surges, Losses Deepen - The Globe and Mail
Major Insider Move at ElectroCore Signals Growing Confidence From the Top - TipRanks
ECOR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
ElectroCore, Inc. (NASDAQ:ECOR) Q4 2025 earnings call transcript - MSN
ElectroCore, Inc. (ECOR) reports Q4 loss, lags revenue estimates - MSN
electroCore stock maintained at Buy by H.C. Wainwright, $18 target - Investing.com India
Electrocore Inc Stock (ECOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.10%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):